Cargando…

Depletion and Reversal of Hepatocellular Carcinoma Inducing CTL through ER Stress-Dependent PERK-CHOP Signaling Pathway

AIMS: In this report, it was investigated that hepatoma cells can cause downregulation of cytotoxic T lymphocyte (CTL) function and tea polyphenols (TPs) can reverse downregulation of CTL function. METHODS: The expression of GRP78, PD-1, and TIM-3 was detected by western blotting in CTLL-2 coculture...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Mengnan, Wang, Wei, Bai, Wen, Bai, Zekun, Chen, Weixi, Su, Yali, Wu, Jinghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576428/
https://www.ncbi.nlm.nih.gov/pubmed/36262827
http://dx.doi.org/10.1155/2022/6413783
_version_ 1784811524974444544
author Guo, Mengnan
Wang, Wei
Bai, Wen
Bai, Zekun
Chen, Weixi
Su, Yali
Wu, Jinghua
author_facet Guo, Mengnan
Wang, Wei
Bai, Wen
Bai, Zekun
Chen, Weixi
Su, Yali
Wu, Jinghua
author_sort Guo, Mengnan
collection PubMed
description AIMS: In this report, it was investigated that hepatoma cells can cause downregulation of cytotoxic T lymphocyte (CTL) function and tea polyphenols (TPs) can reverse downregulation of CTL function. METHODS: The expression of GRP78, PD-1, and TIM-3 was detected by western blotting in CTLL-2 cocultured with Hepa1-6 cells. Moreover, perforin (PRF1) and granzyme B (GzmB) protein levels and ER morphology were examined by ELISA and TEM, respectively. After 4-phenylbutyric acid (4-PBA) or tunicamycin (TM) treatment, programmed cell death protein 1 (PD-1), and mucin domain 3 (TIM-3), PRF1, and GzmB were measured by western blotting and ELISA. After sh-CHOP or GSK2656157 (PERK inhibitor) stimulation, the activation of the PERK-CHOP pathway was detected in CTLL-2 cells. Finally, changes in PD-1, TIM-3, PRF1, and GzmB levels were detected to verify the reversal of CTL depletion by TP. RESULTS: The expression of GRP78, PD-1, and TIM-3 clearly increased, and swelling was observed for the endoplasmic reticulum (ER) in CTLL-2 cells cocultured with hepatoma cells. Concurrently, the levels of PRF1 and GzmB decreased. CTLL-2 depletion was induced after stimulation with TM and differed from 4-PBA stimulation. Treatment with sh-CHOP or GSK2656157 caused a decrease in PD-1 and TIM-3 expression, whereas the expression of PRF1 and GzmB clearly increased. After adding TP, the function of CTLs increased markedly. CONCLUSION: Hepatoma cells induced the depletion of CTLs through the ER stress PERK-CHOP pathway, and TP reversed this depletion by downregulating ER stress.
format Online
Article
Text
id pubmed-9576428
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-95764282022-10-18 Depletion and Reversal of Hepatocellular Carcinoma Inducing CTL through ER Stress-Dependent PERK-CHOP Signaling Pathway Guo, Mengnan Wang, Wei Bai, Wen Bai, Zekun Chen, Weixi Su, Yali Wu, Jinghua Can J Gastroenterol Hepatol Research Article AIMS: In this report, it was investigated that hepatoma cells can cause downregulation of cytotoxic T lymphocyte (CTL) function and tea polyphenols (TPs) can reverse downregulation of CTL function. METHODS: The expression of GRP78, PD-1, and TIM-3 was detected by western blotting in CTLL-2 cocultured with Hepa1-6 cells. Moreover, perforin (PRF1) and granzyme B (GzmB) protein levels and ER morphology were examined by ELISA and TEM, respectively. After 4-phenylbutyric acid (4-PBA) or tunicamycin (TM) treatment, programmed cell death protein 1 (PD-1), and mucin domain 3 (TIM-3), PRF1, and GzmB were measured by western blotting and ELISA. After sh-CHOP or GSK2656157 (PERK inhibitor) stimulation, the activation of the PERK-CHOP pathway was detected in CTLL-2 cells. Finally, changes in PD-1, TIM-3, PRF1, and GzmB levels were detected to verify the reversal of CTL depletion by TP. RESULTS: The expression of GRP78, PD-1, and TIM-3 clearly increased, and swelling was observed for the endoplasmic reticulum (ER) in CTLL-2 cells cocultured with hepatoma cells. Concurrently, the levels of PRF1 and GzmB decreased. CTLL-2 depletion was induced after stimulation with TM and differed from 4-PBA stimulation. Treatment with sh-CHOP or GSK2656157 caused a decrease in PD-1 and TIM-3 expression, whereas the expression of PRF1 and GzmB clearly increased. After adding TP, the function of CTLs increased markedly. CONCLUSION: Hepatoma cells induced the depletion of CTLs through the ER stress PERK-CHOP pathway, and TP reversed this depletion by downregulating ER stress. Hindawi 2022-10-10 /pmc/articles/PMC9576428/ /pubmed/36262827 http://dx.doi.org/10.1155/2022/6413783 Text en Copyright © 2022 Mengnan Guo et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Guo, Mengnan
Wang, Wei
Bai, Wen
Bai, Zekun
Chen, Weixi
Su, Yali
Wu, Jinghua
Depletion and Reversal of Hepatocellular Carcinoma Inducing CTL through ER Stress-Dependent PERK-CHOP Signaling Pathway
title Depletion and Reversal of Hepatocellular Carcinoma Inducing CTL through ER Stress-Dependent PERK-CHOP Signaling Pathway
title_full Depletion and Reversal of Hepatocellular Carcinoma Inducing CTL through ER Stress-Dependent PERK-CHOP Signaling Pathway
title_fullStr Depletion and Reversal of Hepatocellular Carcinoma Inducing CTL through ER Stress-Dependent PERK-CHOP Signaling Pathway
title_full_unstemmed Depletion and Reversal of Hepatocellular Carcinoma Inducing CTL through ER Stress-Dependent PERK-CHOP Signaling Pathway
title_short Depletion and Reversal of Hepatocellular Carcinoma Inducing CTL through ER Stress-Dependent PERK-CHOP Signaling Pathway
title_sort depletion and reversal of hepatocellular carcinoma inducing ctl through er stress-dependent perk-chop signaling pathway
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576428/
https://www.ncbi.nlm.nih.gov/pubmed/36262827
http://dx.doi.org/10.1155/2022/6413783
work_keys_str_mv AT guomengnan depletionandreversalofhepatocellularcarcinomainducingctlthrougherstressdependentperkchopsignalingpathway
AT wangwei depletionandreversalofhepatocellularcarcinomainducingctlthrougherstressdependentperkchopsignalingpathway
AT baiwen depletionandreversalofhepatocellularcarcinomainducingctlthrougherstressdependentperkchopsignalingpathway
AT baizekun depletionandreversalofhepatocellularcarcinomainducingctlthrougherstressdependentperkchopsignalingpathway
AT chenweixi depletionandreversalofhepatocellularcarcinomainducingctlthrougherstressdependentperkchopsignalingpathway
AT suyali depletionandreversalofhepatocellularcarcinomainducingctlthrougherstressdependentperkchopsignalingpathway
AT wujinghua depletionandreversalofhepatocellularcarcinomainducingctlthrougherstressdependentperkchopsignalingpathway